(Q39465163)

12 September 2017

1 reference

title

Lipophilicity, hydrophilicity, and the central nervous system side effects of beta blockers (English)

1 reference

12 September 2017

0 references

D E Drayer

1

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 January 1987

1 reference

12 September 2017

1 reference

12 September 2017

volume

7

1 reference

12 September 2017

issue

4

1 reference

12 September 2017

page(s)

87-91

1 reference

Clinical Consequences of the Lipophilicity and Plasma Protein Binding of Antiarrhythmic Drugs and Active Metabolites in Man

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04029.X

Beta-adrenergic blocking drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04029.X

Beta-adrenoceptor blockers and the blood-brian barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04029.X

beta-Adrenoceptor antagonists: new drugs and new indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04029.X

Beta blockers in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04029.X

Central actions of β-adrenoceptor blocking drugs in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04029.X

Bevantolol hydrochloride--preclinical pharmacologic profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04029.X

Blood-brain barrier: interface between internal medicine and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04029.X

The central uptake of beta-adrenoceptor antagonists [proceedings]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04029.X

Cerebrospinal fluid concentrations of propranolol, pindolol and atenolol in man: evidence for central actions of beta-adrenoceptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04029.X

Safety profile of bevantolol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04029.X

Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB04029.X

10.1002/J.1875-9114.1987.TB04029.X

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference